EVOK Dividend History & Analysis | 100% Free Data

EVOK's dividend history, current yield (0%), dividend growth rate (N/A), complete payout history and peer comparison (Pharmaceuticals).

As of July 2025, Evoke Pharma (EVOK) does not pay a dividend.

Top Dividend Payers in Pharmaceuticals

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
SIGA 466 M 9.32% 12.5%
PFE 147,830 M 6.68% 6.33%
OGN 2,584 M 6.87% 3.15%
GS71 77,207 M 4.94% 5.81%
GSK 79,996 M 4.28% 6.15%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (5y CAGR) Payout Consistency
RDY 12,171 M 54.2% 93.0%
RPRX 20,449 M 22.9% 100%
ZTS 70,699 M 16.7% 100%
LLY 711,914 M 11.9% 99.5%
NVO 324,255 M 17.3% 93.9%

Similar Stocks with Attractive Dividends

SIGA
KRK
Krka d. d
4.37% Yield
MRK
Merck
3.55% Yield
ZTS
Zoetis
1.45% Yield
SAN
Sanofi
4.45% Yield
NVO
Novo Nordisk
2.08% Yield

EVOK Dividend History: as of July 2025

No dividends paid yet.

EVOK Dividend FAQ

Does EVOK pay a dividend?

As of July 2025 EVOK does not pay a dividend.

What is the Dividend Yield of EVOK?

As of July 2025, EVOK`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 5.74.

How often does EVOK pay dividends?

Over the last 12 months, EVOK has issued dividend payments.

Will EVOK pay dividends in 2025?

The next Ex-Dividend date for Evoke Pharma (EVOK) is currently unknown.

What is the next Ex-Dividend Date for EVOK?

The next Ex-Dividend date for Evoke Pharma (EVOK) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of EVOK?

EVOK's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of EVOK?

EVOK's 5-Year Yield on Cost is -%. If you bought EVOK's shares at 552.96 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of EVOK?

EVOK Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does EVOK have a good Dividend Yield?

EVOK`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of EVOK?

The Dividend Payout Ratio of EVOK is unknown.

What is the Dividend Rating of EVOK?

EVOK`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

EVOK Outstanding Shares Analysis

What is the Trend in EVOK`s Outstanding Shares?

Evoke Pharma`s outstanding shares have increased by approximately 62.23% annually over the past 5 years (Correlation: 70.0%), negatively influencing the share price.

Has Evoke Pharma ever had a Stock Split?

Yes, the last Stock Split was on 2024-08-01 with a factor of 1:12. This reverse stock split decreased the number of shares and increased the price per share by a ratio of 0.08.
Year Number of Shares Annual Growth Rate
2012 9,400
2013 14,800 +57.45%
2014 42,100 +184.46%
2015 49,500 +17.58%
2016 85,500 +72.73%
2017 106,700 +24.8%
2018 121,000 +13.4%
2019 168,800 +39.5%
2020 184,900 +9.54%
2021 226,800 +22.66%
2022 278,600 +22.84%
2023 3,343,100 +1099.96%
2024 1,486,000 -55.55%
2025 2,548,700 +71.51%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid per year (typically quarterly).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.